(Q45871057)

17 December 2017

title

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma (English)

1 reference

17 December 2017

0 references

Moriuchi S

1

1 reference

17 December 2017

Krisky DM

2

1 reference

17 December 2017

Marconi PC

3

1 reference

17 December 2017

Tamura M

4

1 reference

17 December 2017

Shimizu K

5

1 reference

17 December 2017

Yoshimine T

6

1 reference

17 December 2017

Cohen JB

7

1 reference

17 December 2017

Glorioso JC

8

1 reference

17 December 2017

publication date

1 September 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

17

1 reference

17 December 2017

page(s)

1483-1490

1 reference

17 December 2017

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Adenovirus-mediated gene therapy of experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene Transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Replication-defective herpes simplex virus vectors for gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Gene transfer to muscle using herpes simplex virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Rapid method for construction of recombinant HSV gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Connexin 43-enhanced suicide gene therapy using herpesviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Development of replication-defective herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

Results of three consecutive combined treatments for malignant gliomas. Ten-year experience at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

7 January 2021

National survey of patterns of care for brain-tumor patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

7 January 2021

Treatment of gliomas in adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

7 January 2021

Chemotherapy for gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

7 January 2021

Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301265

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301265

1 reference

17 December 2017

Dimensions Publication ID

1041732189

0 references

1 reference

17 December 2017